This article is more than 5 years old. Information may no longer be current.

FDA approves STAAR's Visian Toric ICL for myopia with astigmatism

Issue: October 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical’s Visian Toric Implantable Collamer Lens has been approved by the FDA for the correction of myopia with astigmatism, according to a company press release.

The approval expands the company’s ICL indications, the release said.

“FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom,” STAAR President and CEO Caren Mason said in the release.

The Visian Toric ICL is expected to be available in the U.S. on Nov. 1, the release said.